Product NDC: | 49771-002 |
Proprietary Name: | Mitosol |
Non Proprietary Name: | mitomycin |
Active Ingredient(s): | & nbsp; mitomycin |
Administration Route(s): | URETERAL |
Dosage Form(s): | KIT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49771-002 |
Labeler Name: | Mobius Therapeutics LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022572 |
Marketing Category: | NDA |
Start Marketing Date: | 20120208 |
Package NDC: | 49771-002-03 |
Package Description: | 3 TRAY in 1 CARTON (49771-002-03) > 1 KIT in 1 TRAY (49771-002-01) * 1 mL in 1 SYRINGE * 1 APPLICATOR in 1 PACKET (53329-805-09) > 5 mL in 1 APPLICATOR * 1 mL in 1 VIAL, SINGLE-USE |
NDC Code | 49771-002-03 |
Proprietary Name | Mitosol |
Package Description | 3 TRAY in 1 CARTON (49771-002-03) > 1 KIT in 1 TRAY (49771-002-01) * 1 mL in 1 SYRINGE * 1 APPLICATOR in 1 PACKET (53329-805-09) > 5 mL in 1 APPLICATOR * 1 mL in 1 VIAL, SINGLE-USE |
Product NDC | 49771-002 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | mitomycin |
Dosage Form Name | KIT |
Route Name | URETERAL |
Start Marketing Date | 20120208 |
Marketing Category Name | NDA |
Labeler Name | Mobius Therapeutics LLC |
Substance Name | |
Strength Number | |
Strength Unit | |
Pharmaceutical Classes |